EP3035965
Tvísértækar eingildar mótefnatvenndir sem geta bundið CD123 og CD3, og notkun þeirra
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
20.8.2014EP published:
11.11.2020EP application number:
14837858.1
EP translation filed:
12.2.2021Grant published:
15.3.2021EPO information:
European Patent Register
Max expiry date:
19.8.2034Expiry date:
19.8.2022
Title:
BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING CD123 AND CD3, AND USES THEROF
Timeline
Today
20.8.2014EP application
11.11.2020EP Publication
12.2.2021Translation submitted
15.3.2021Registration published
19.8.2022Expires
Owner
Name:
MacroGenics, Inc.Address:
9704 Medical Center Drive, Rockville, MD 20850, US
Inventor
Name:
BONVINI, EzioAddress:
Potomac, MD 20854, US
Name:
JOHNSON, Leslie S.Address:
Darnestown, MD 20874, US
Name:
HUANG, LingAddress:
Bethesda, MD 20818, US
Name:
MOORE, Paul A.Address:
Bethesda, MD 20878, US
Name:
CHICHILI, Gurunadh ReddyAddress:
Germantown, MD 20874, US
Name:
ALDERSON, Ralph FromanAddress:
North Potomac, MD 20878, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201361869510 PDate:
23.8.2013Country:
US
Number:
201361907749 PDate:
22.11.2013Country:
US
Number:
13198784Date:
20.12.2013Country:
EP
Number:
201461990475 PDate:
8.5.2014Country:
US
Classification
Categories:
A61P 11/06, A61P 17/02, A61P 19/02, A61P 35/04, A61P 37/00, A61P 37/08, C07K 16/28, A61K 39/00, A61P 35/00, A61P 35/02, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 23.8.2021
Expires: 19.8.2022
Payer: Árnason Faktor ehf.